BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22726816)

  • 1. Perceptions of genetic research and testing among members of families with an increased risk of malignant melanoma.
    Bränström R; Kasparian NA; Affleck P; Tibben A; Chang YM; Azizi E; Baron-Epel O; Bergman W; Chan M; Davies J; Ingvar C; Kanetsky PA; van Leeuwen E; Olsson H; Gruis NA; Brandberg Y; Newton-Bishop J
    Eur J Cancer; 2012 Nov; 48(16):3052-62. PubMed ID: 22726816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination.
    Kasparian NA; Bränström R; Chang YM; Affleck P; Aspinwall LG; Tibben A; Azizi E; Baron-Epel O; Battistuzzi L; Bruno W; Chan M; Cuellar F; Debniak T; Pjanova D; Ertmanski S; Figl A; Gonzalez M; Hayward NK; Hocevar M; Kanetsky PA; Leachman S; Bergman W; Heisele O; Palmer J; Peric B; Puig S; Schadendorf D; Gruis NA; Newton-Bishop J; Brandberg Y;
    Arch Dermatol; 2012 Oct; 148(10):1142-51. PubMed ID: 22801744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.
    Aspinwall LG; Stump TK; Taber JM; Drummond DM; Kohlmann W; Champine M; Leachman SA
    Transl Behav Med; 2018 Jan; 8(1):29-43. PubMed ID: 29385581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary melanoma and predictive genetic testing: why not?
    Riedijk SR; de Snoo FA; van Dijk S; Bergman W; van Haeringen A; Silberg S; van Elderen TM; Tibben A
    Psychooncology; 2005 Sep; 14(9):738-45. PubMed ID: 15744786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the emotional and behavioural reactions to receiving personalized melanoma genomic risk information: a qualitative study.
    Fenton GL; Smit AK; Keogh L; Cust AE
    Br J Dermatol; 2019 Jun; 180(6):1390-1396. PubMed ID: 30580464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family members' perceptions of genetic testing for malignant melanoma--a prospective interview study.
    Bergenmar M; Hansson J; Brandberg Y
    Eur J Oncol Nurs; 2009 Apr; 13(2):74-80. PubMed ID: 19179113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma.
    Taber JM; Aspinwall LG; Drummond DM; Stump TK; Kohlmann W; Champine M; Cassidy P; Leachman SA
    Ann Behav Med; 2021 Feb; 55(1):24-40. PubMed ID: 32415830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients' Sociodemographic Background and Counseling Experience.
    Gilbar R; Shalev S; Spiegel R; Pras E; Berkenstadt M; Sagi M; Ben-Yehuda A; Mor P; Perry S; Zaccai TF; Borochowitz Z; Barnoy S
    J Genet Couns; 2016 Apr; 25(2):314-24. PubMed ID: 26371363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Views of Icelandic women towards genetic counseling - and testing of BRCA2 mutations].
    Jonsdottir T; Valdimarsdottir H; Tryggvadottir L; Lund SH; Thordardottir M; Magnusson MK; Valdimarsdottir U
    Laeknabladid; 2018 Juni; 104(6):289-296. PubMed ID: 29863481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRAMe: Familial Risk Assessment of Melanoma-a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma.
    Holland EA; Lo S; Kelly B; Schmid H; Cust AE; Palmer JM; Drummond M; Hayward NK; Pritchard AL; Mann GJ
    Fam Cancer; 2021 Jul; 20(3):231-239. PubMed ID: 32989607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families.
    Kasparian NA; Meiser B; Butow PN; Simpson JM; Mann GJ
    Genet Med; 2009 Apr; 11(4):265-78. PubMed ID: 19265718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a family systems approach to investigate cancer risk communication within melanoma families.
    Harris JN; Hay J; Kuniyuki A; Asgari MM; Press N; Bowen DJ
    Psychooncology; 2010 Oct; 19(10):1102-11. PubMed ID: 20119933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma high-risk families' perceived health care provider risk communication.
    Loescher LJ; Crist JD; Cranmer L; Curiel-Lewandrowski C; Warneke JA
    J Cancer Educ; 2009; 24(4):301-7. PubMed ID: 19838889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study.
    Kasparian NA; Meiser B; Butow PN; Soames Job RF; Mann GJ
    Psychooncology; 2007 Jan; 16(1):69-78. PubMed ID: 16874747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better the devil you know? High-risk individuals' anticipated psychological responses to genetic testing for melanoma susceptibility.
    Kasparian NA; Meiser B; Butow PN; Job RF; Mann GJ
    J Genet Couns; 2006 Dec; 15(6):433-47. PubMed ID: 17103321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communication Among Melanoma Family Members.
    Bowen DJ; Albrecht T; Hay J; Eggly S; Harris-Wei J; Meischke H; Burke W
    J Health Commun; 2017 Mar; 22(3):198-204. PubMed ID: 28248624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived intrafamily melanoma risk communication.
    Loescher LJ; Crist JD; Siaki LA
    Cancer Nurs; 2009; 32(3):203-10. PubMed ID: 19295423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
    Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
    J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result.
    Leof ER; Zhu X; Rabe KG; McCormick JB; Petersen GM; Radecki Breitkopf C
    Genet Med; 2019 Nov; 21(11):2468-2477. PubMed ID: 30992552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing in familial melanoma: uptake and implications.
    de Snoo FA; Riedijk SR; van Mil AM; Bergman W; ter Huurne JA; Timman R; Bertina W; Gruis NA; Vasen HF; van Haeringen A; Breuning MH; Tibben A
    Psychooncology; 2008 Aug; 17(8):790-6. PubMed ID: 18613292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.